Sunshine Biopharma
Open
$2.32
Prev. Close
$2.32
High
$2.32
Low
$2.25
Market Snapshot
$1.09M
-0.2
-6.59
$34.87M
50
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. The company is headquartered in Fort Lauderdale, Florida and currently employs 50 full-time employees. The company went IPO on 2008-08-15. The firm has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for the treatment of SARS Coronavirus infections. The firm operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The firm operates two wholly owned subsidiaries: Nora Pharma Inc., which has a portfolio of pharmaceutical products consisting of various prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells nonprescription over-the-counter (OTC) products.
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. The company is headquartered in Fort Lauderdale, Florida and currently employs 50 full-time employees. The company went IPO on 2008-08-15. The firm has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for the treatment of SARS Coronavirus infections. The firm operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The firm operates two wholly owned subsidiaries: Nora Pharma Inc., which has a portfolio of pharmaceutical products consisting of various prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells nonprescription over-the-counter (OTC) products.
Recently from Cashu
Sunshine Biopharma Launches New Generic Drug, Expanding Affordable Healthcare Solutions
Sunshine Biopharma Expands Product Portfolio with New Generic Drug Launch Sunshine Biopharma Inc., a Florida-based pharmaceutical company, announces the launch of a new generic prescription drug, mark…
Sunshine Biopharma (SBFM) Launches Generic Drug to Expand Market Reach and Accessibility
Sunshine Biopharma Launches New Generic Drug, Enhancing Market Reach Sunshine Biopharma Inc. (NASDAQ:SBFM) announces the launch of a new generic prescription drug, marking a pivotal moment for the Flo…
Sunshine Biopharma Launches New Generic Drug to Enhance Patient Access and Market Position
Sunshine Biopharma Expands Product Portfolio with New Generic Drug Launch Sunshine Biopharma Inc. announces the launch of a new generic prescription drug, a strategic initiative that reflects the comp…